We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. When comparing median FEV 1 before vs. 3 years after ...
Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by ...
Acute myeloid leukemia (AML) is a deadly disease that presents unique treatment challenges. The cancerous hematopoietic stem and progenitor cells (HSPC) can be treated using chimeric antigen receptor ...
Erin Eun-Young Ahn, Ph.D., an associate professor in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, was recently awarded an R01 from the National Institute of Health’s ...
Case CCC Immune Oncology Program member, Amar Desai, PhD, has been awarded $100,000 in funding for one year from the Innovative Science Accelerator Program (ISAC) for his project Antihistamines to ...
The bone marrow serves as the main site of hematopoiesis in humans, giving rise to red and white blood cells. This space is highly organized into distinct regions, or niches, that perform different ...
This study is led by Prof. Ren Sun (Westlake University) and research fellow Yushen Du (Cancer Institute, the Second Affiliated Hospital, Zhejiang University School of Medicine). Myelotoxicity is the ...
Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results